UCB's Global Corporate Website
Welcome to UCB in the United States

Apr

22

Contributing to Environmental Sustainability this Earth Day and Every Day

Apr

13

UCB Community Health Fund Supports U.S. Organizations Addressing Mental Health and Young People

UCB recently announced the funding recipients for the UCB Community Health Fund’s 2021 call for projects, focused on the needs of vulnerable young people in the wake of COVID-19. Three U.S.-based organizations will receive support from the Fund for projects addressing the mental health of vulnerable young people. 

 

Apr

02

Advancing Our Mission to Cure Epilepsy

With nearly 30 years of experience in epilepsy, UCB can and will unlock what's possible for the millions of people living with epilepsy, so their reality can be free from seizures and the other debilitating and unpredictable impacts of the disease. Hear from Mike Davis, Head of U.S. Neurology and Rare, share our plan to impact the underlying causes of the disease and to discover, develop, and deliver highly differentiated medicines that will transform and, ultimately, cure the disease, so that people living with epilepsy can live their ideal life, every day.

Mar

25

UCB at the 2022 AAD Annual Meeting: Our Commitment to Advancing Science in Dermatology

 

 

Mar

24

North Carolina Academic Engagement Night - Investing in our Future through STEM

At UCB, we are committed to accelerating scientific discoveries by supporting innovation ultimately leading to the discovery of new solutions to help people capture the moments that matter. Part of this commitment is a strong foundational support for STEM education in our communities to help inspire the next generation of scientists.

Mar

15

Voices on Value: Building a Sustainable Healthcare System Together – Our U.S. Sustainable Access and Pricing Transparency Report

Last year, UCB launched its Voices on Value blog series to foster a dialogue around how to make our health system better, stronger, and more accessible now and in the future. To advance this dialogue, UCB is releasing its first-ever U.S. Sustainable Access and Pricing Transparency Report, which underscores UCB’s commitment to an innovative, competitive, and value-based system. 

Feb

25

Recognizing Rare Disease Day Every Day – The Importance of Addressing Unmet Patient Needs

At UCB, we work 365-days-a-year to find new ways to deliver solutions, peace of mind, and opportunities to people living with severe diseases because everyone deserves to live the best life they can.

Feb

22

Partnering for Greater Impact with Microsoft in R&D

At UCB, our aim is to amplify the power of scientific innovation through digital transformation, ensuring we deliver the best individual experience so patients can live their best lives. As part of that effort, we are integrating artificial intelligence (AI) across the research and development organization to bring accelerated solutions to patients with unmet needs. 

Dec

03

Unleashing the Power of Digital Solutions in Epilepsy Care

UCB’s Head of Digital Business Transformation, Colin Lake speaks to the current landscape in digital business transformation and neurology.

Dec

02

Working Toward a More Equitable Future: Addressing Barriers in the Hispanic Epilepsy Community

To better understand the experiences of Hispanic people with epilepsy and to improve our collective effort to break down barriers to equitable health outcomes, UCB is working with patients and their families, as well as health equity experts. Learn more.